Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$10,144,251
+$1,491,878 QoQ
Shares Held
421,273
+36.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#425
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$161,392
PutShares
4,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $485,897,181 across 15 Drug Manufacturers - General names. PFE ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,252 | $137,037,286 | |
| 2 | ABBV |
AbbVie Inc.
|
459,683 | $115,674,628 | |
| 3 | JNJ |
Johnson & Johnson
|
392,685 | $99,730,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
378,859 | $48,683,381 | |
| 5 | AMGN |
Amgen Inc
|
77,970 | $28,234,494 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
153,825 | $19,434,249 | |
| 7 | PFE |
Pfizer Inc
This page
|
421,273 | $10,144,251 | |
| 8 | AZN |
Astrazeneca PLC
|
41,103 | $7,793,949 |
All Filings in PFE
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,144,251 | 421,273 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $8,652,373 | 308,133 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $11,196,906 | 449,675 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $11,285,497 | 442,916 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,718,429 | 277,163 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $9,556,143 | 377,117 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,898,797 | 335,424 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,157,620 | 350,989 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,382,476 | 335,328 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $8,489,917 | 305,943 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,623,303 | 264,790 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,465,016 | 255,201 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,614,999 | 398,446 | Shares | Sole | 2023-08-09 | |
| 2023-06-30 | $161,392 | 4,400 | Put | Sole | 2023-08-09 | |
| 2023-03-31 | $465,120 | 11,400 | Put | Sole | 2023-05-15 | |
| 2023-03-31 | $16,448,600 | 403,152 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,858,881 | 309,502 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $584,136 | 11,400 | Put | Sole | 2023-02-14 | |
| 2022-09-30 | $498,864 | 11,400 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $10,067,950 | 230,072 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,265,107 | 233,933 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $230,692 | 4,400 | Put | Sole | 2022-08-15 | |
| 2022-03-31 | $14,077,194 | 271,918 | Shares | Sole | 2022-05-17 | |
| 2022-03-31 | $227,788 | 4,400 | Put | Sole | 2022-05-17 | |
| 2021-12-31 | $14,067,186 | 238,225 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $9,431,619 | 219,289 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $9,731,181 | 248,498 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,602,596 | 237,444 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,915,310 | 187,865 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,570,100 | 151,774 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,469,440 | 167,261 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,719,443 | 144,591 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||